Renato Fanin Selected Research

fludarabine

1/2021	Thiotepa-busulfan-fludarabine (TBF) conditioning regimen in patients undergoing allogeneic hematopoietic cell transplantation for myelofibrosis: an outcome analysis from the Chronic Malignancies Working Party of the EBMT.
1/2019	Busulfan- or Thiotepa-Based Conditioning in Myelofibrosis: A Phase II Multicenter Randomized Study from the GITMO Group.
7/2010	Fludarabine-based induction therapy does not overcome the negative effect of ABCG2 (BCRP) over-expression in adult acute myeloid leukemia patients.
10/2009	FLAIE (fludarabine, cytarabine, idarubicin, and etoposide), a four drug induction chemotherapy for adult acute myeloid leukemia: A single center experience.
12/2008	Gemtuzumab-ozogamicin in combination with fludarabine, cytarabine, idarubicin (FLAI-GO) as induction therapy in CD33-positive AML patients younger than 65 years.
11/2008	Incidence of bacterial and fungal infections in newly diagnosed acute myeloid leukaemia patients younger than 65 yr treated with induction regimens including fludarabine: retrospective analysis of 224 cases.
12/2003	Fludarabine + prednisone +/- alpha-interferon followed or not by alpha-interferon maintenance therapy for previously untreated patients with chronic lymphocytic leukemia: long term results of a randomized study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Renato Fanin Research Topics

Disease

37	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 04/2024 - 05/2002
18	Multiple Myeloma 01/2022 - 07/2002
16	Neoplasms (Cancer) 01/2023 - 04/2004
16	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 01/2021 - 02/2002
13	Graft vs Host Disease (Graft-Versus-Host Disease) 04/2024 - 11/2002
11	Leukemia 05/2024 - 09/2003
11	Infections 04/2023 - 10/2004
10	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2023 - 01/2002
9	Hematologic Neoplasms (Hematological Malignancy) 10/2023 - 09/2003
7	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2022 - 10/2004
7	Primary Myelofibrosis (Myelosclerosis) 01/2021 - 10/2008
6	COVID-19 04/2023 - 01/2021
5	Lymphoma (Lymphomas) 12/2020 - 09/2003
5	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 11/2013 - 11/2003
4	Mycoses (Diseases, Fungus) 12/2021 - 11/2008
4	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2021 - 08/2008
4	Pathologic Complete Response 01/2017 - 10/2005
3	Hemorrhage 12/2023 - 07/2003
3	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 12/2018 - 10/2004
3	Thrombocytopenia (Thrombopenia) 12/2018 - 02/2002
3	Residual Neoplasm 12/2017 - 01/2009
3	Autoimmune Hemolytic Anemia (Cold Agglutinin Disease) 04/2012 - 02/2002
3	Autoimmune Diseases (Autoimmune Disease) 03/2006 - 05/2003
3	Acute Promyelocytic Leukemia 05/2004 - 05/2002
2	Aplastic Anemia (Anemia, Hypoplastic) 04/2024 - 05/2006
2	Febrile Neutropenia 10/2020 - 08/2005
2	Essential Thrombocythemia 01/2019 - 04/2004
2	Thrombosis (Thrombus) 12/2018 - 05/2016
2	Invasive Fungal Infections 11/2018 - 09/2005
2	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 01/2017 - 03/2012
2	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 10/2015 - 01/2007
2	Hodgkin Disease (Hodgkin's Disease) 04/2015 - 04/2002
2	Myeloproliferative Disorders (Myeloproliferative Disorder) 06/2014 - 04/2004
2	Cardiotoxicity 01/2014 - 06/2008
2	B-Cell Lymphoma (Lymphoma, B Cell) 01/2014 - 05/2003
2	Fever (Fevers) 10/2004 - 05/2003
2	Hemolytic Anemia 11/2003 - 02/2002

Drug/Important Bio-Agent (IBA)

17	Rituximab (Mabthera)FDA Link 01/2020 - 02/2002
13	Imatinib Mesylate (Gleevec)FDA Link 01/2023 - 01/2005
10	Inosine Triphosphate (ITP)IBA 01/2021 - 02/2002
9	Proteins (Proteins, Gene)FDA Link 01/2016 - 01/2002
8	Cyclophosphamide (Cytoxan)FDA LinkGeneric 04/2024 - 11/2022
7	Tyrosine Kinase InhibitorsIBA 01/2023 - 01/2017
7	fludarabineIBA 01/2021 - 12/2003
5	Bortezomib (Velcade)FDA Link 01/2022 - 02/2005
5	Cyclosporine (Ciclosporin)FDA LinkGeneric 01/2020 - 10/2004
5	Idarubicin (4 Demethoxydaunorubicin)FDA LinkGeneric 03/2013 - 05/2002
5	Dexamethasone (Maxidex)FDA LinkGeneric 03/2013 - 06/2006
4	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2020 - 01/2002
4	SteroidsIBA 11/2018 - 11/2004
4	Etoposide (VP 16)FDA LinkGeneric 01/2018 - 10/2005
4	Cytarabine (Cytosar-U)FDA LinkGeneric 01/2018 - 10/2005
3	Dasatinib (BMS 354825)FDA Link 01/2023 - 01/2013
3	venetoclaxIBA 01/2023 - 01/2022
3	nilotinib FDA Link 01/2023 - 01/2009
3	Lenalidomide (CC 5013)FDA Link 01/2022 - 03/2012
3	Busulfan (Busulfex)FDA Link 01/2021 - 04/2004
3	Bendamustine Hydrochloride FDA Link 01/2017 - 09/2013
3	Biomarkers (Surrogate Marker)IBA 01/2017 - 03/2012
3	AnthracyclinesIBA 01/2014 - 05/2004
3	Thalidomide (Thalomid)FDA Link 12/2011 - 05/2003
3	AutoantibodiesIBA 03/2006 - 02/2002
2	Messenger RNA (mRNA)IBA 04/2023 - 01/2022
2	HLA Antigens (Human Leukocyte Antigens)IBA 01/2022 - 09/2014
2	Antineoplastic Agents (Antineoplastics)IBA 01/2022 - 01/2014
2	AzolesIBA 12/2021 - 09/2005
2	AntibodiesIBA 08/2021 - 05/2003
2	Thiotepa (Triethylenethiophosphoramide)FDA LinkGeneric 01/2021 - 01/2019
2	Thrombopoietin ReceptorsIBA 01/2021 - 05/2016
2	eltrombopag FDA Link 01/2021 - 12/2018
2	Azacitidine (5 Azacytidine)FDA Link 01/2021 - 06/2013
2	Decitabine FDA Link 01/2021 - 01/2019
2	Anti-Bacterial Agents (Antibiotics)IBA 11/2020 - 10/2004
2	Meropenem (Merrem)FDA LinkGeneric 10/2020 - 08/2020
2	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 01/2020 - 01/2007
2	Antilymphocyte Serum (Anti-Thymocyte Globulin)IBA 01/2020 - 05/2006
2	ruxolitinibIBA 04/2019 - 10/2017
2	SuspensionsIBA 12/2018 - 01/2017
2	posaconazole FDA Link 11/2018 - 12/2013
2	Proton Pump InhibitorsIBA 11/2018 - 12/2013
2	Immunoglobulins (Immunoglobulin)IBA 01/2017 - 10/2015
2	Member 2 Subfamily G ATP Binding Cassette TransporterIBA 03/2013 - 05/2011
2	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 06/2006 - 11/2002
2	Amifostine (Ethyol)FDA LinkGeneric 04/2006 - 04/2004
2	Daunorubicin (Cerubidine)FDA LinkGeneric 04/2006 - 01/2003
2	Infliximab (Remicade)FDA Link 11/2004 - 10/2004
2	Prednisone (Sone)FDA LinkGeneric 10/2004 - 12/2003

Therapy/Procedure

40	Therapeutics 01/2023 - 05/2002
35	Stem Cell Transplantation 04/2024 - 04/2002
20	Hematopoietic Stem Cell Transplantation 01/2023 - 02/2005
19	Drug Therapy (Chemotherapy) 10/2021 - 01/2002
14	Transplantation 05/2024 - 09/2003
8	Salvage Therapy 12/2020 - 03/2012
7	Cell Transplantation 01/2023 - 06/2006
7	Homologous Transplantation 01/2022 - 06/2006
4	Induction Chemotherapy 11/2018 - 11/2008
4	Autologous Transplantation 01/2018 - 09/2003
3	Haploidentical Transplantation 11/2022 - 01/2022
2	Splenectomy 01/2019 - 05/2016
2	Radiotherapy 04/2015 - 07/2005